BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 22709693)

  • 1. Cryopreserved ovarian cortex from patients with leukemia in complete remission contains no apparent viable malignant cells.
    Greve T; Clasen-Linde E; Andersen MT; Andersen MK; Sørensen SD; Rosendahl M; Ralfkiaer E; Andersen CY
    Blood; 2012 Nov; 120(22):4311-6. PubMed ID: 22709693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian tissue cryopreserved for fertility preservation from patients with Ewing or other sarcomas appear to have no tumour cell contamination.
    Greve T; Wielenga VT; Grauslund M; Sørensen N; Christiansen DB; Rosendahl M; Yding Andersen C
    Eur J Cancer; 2013 May; 49(8):1932-8. PubMed ID: 23452988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eliminating malignant cells from cryopreserved ovarian tissue is possible in leukaemia patients.
    Soares M; Saussoy P; Maskens M; Reul H; Amorim CA; Donnez J; Dolmans MM
    Br J Haematol; 2017 Jul; 178(2):231-239. PubMed ID: 28419412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of ovarian tissue transplantation in patients with borderline ovarian tumors.
    Masciangelo R; Bosisio C; Donnez J; Amorim CA; Dolmans MM
    Hum Reprod; 2018 Feb; 33(2):212-219. PubMed ID: 29281007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal residual disease detection of leukemic cells in ovarian cortex by eight-color flow cytometry.
    Amiot C; Angelot-Delettre F; Zver T; Alvergnas-Vieille M; Saas P; Garnache-Ottou F; Roux C
    Hum Reprod; 2013 Aug; 28(8):2157-67. PubMed ID: 23633552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination.
    Shapira M; Raanani H; Barshack I; Amariglio N; Derech-Haim S; Marciano MN; Schiff E; Orvieto R; Meirow D
    Fertil Steril; 2018 Jan; 109(1):48-53. PubMed ID: 29198847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reimplantation of cryopreserved ovarian tissue from patients with acute lymphoblastic leukemia is potentially unsafe.
    Dolmans MM; Marinescu C; Saussoy P; Van Langendonckt A; Amorim C; Donnez J
    Blood; 2010 Oct; 116(16):2908-14. PubMed ID: 20595517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients.
    Dolmans MM; Iwahara Y; Donnez J; Soares M; Vaerman JL; Amorim CA; Poirel H
    Hum Reprod; 2016 Oct; 31(10):2292-302. PubMed ID: 27591237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients.
    Zver T; Frontczak S; Poirot C; Rives-Feraille A; Leroy-Martin B; Koscinski I; Arbez-Gindre F; Garnache-Ottou F; Roux C; Amiot C
    J Ovarian Res; 2022 Jan; 15(1):9. PubMed ID: 35042558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ninety-five orthotopic transplantations in 74 women of ovarian tissue after cytotoxic treatment in a fertility preservation network: tissue activity, pregnancy and delivery rates.
    Van der Ven H; Liebenthron J; Beckmann M; Toth B; Korell M; Krüssel J; Frambach T; Kupka M; Hohl MK; Winkler-Crepaz K; Seitz S; Dogan A; Griesinger G; Häberlin F; Henes M; Schwab R; Sütterlin M; von Wolff M; Dittrich R;
    Hum Reprod; 2016 Sep; 31(9):2031-41. PubMed ID: 27378768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety of ovarian cryopreservation and transplantation in patients with acute leukemia: a case series.
    Sönmezer M; Şükür YE; Saçıntı KG; Özkavukçu S; Kankaya D; Atabekoğlu CS; Cengiz Seval G; Oktay KH
    Am J Obstet Gynecol; 2024 Jan; 230(1):79.e1-79.e10. PubMed ID: 37666382
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of transplanting cryopreserved ovarian tissue in cancer patients: a review of the literature.
    Rosendahl M; Greve T; Andersen CY
    J Assist Reprod Genet; 2013 Jan; 30(1):11-24. PubMed ID: 23263841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New methods to improve the safety assessment of cryopreserved ovarian tissue for fertility preservation in breast cancer patients.
    Rodríguez-Iglesias B; Novella-Maestre E; Herraiz S; Díaz-García C; Pellicer N; Pellicer A
    Fertil Steril; 2015 Dec; 104(6):1493-502.e1-2. PubMed ID: 26364839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating the safety and efficacy of cryopreserved ovarian tissue transplantation in leukemia patients with different bone marrow remission status using xenotransplantation.
    Li Y; Ruan X; Gu M; Du J; Jin F; Cheng J; Li Y; Jiang L; Wang Z; Yang Y; Zhang M; Mueck AO
    Front Endocrinol (Lausanne); 2024; 15():1364316. PubMed ID: 38590823
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone does not prevent malignant cell reintroduction in leukemia patients undergoing ovarian transplant: risk assessment of leukemic cell transmission by a xenograft model.
    Díaz-García C; Herraiz S; Such E; Andrés MDM; Villamón E; Mayordomo-Aranda E; Cervera JV; Sanz MA; Pellicer A
    Hum Reprod; 2019 Aug; 34(8):1485-1493. PubMed ID: 31339993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cancer chemotherapy before ovarian cortex cryopreservation on ovarian tissue transplantation.
    Poirot C; Fortin A; Lacorte JM; Akakpo JP; Genestie C; Vernant JP; Brice P; Morice P; Leblanc T; Gabarre J; Delmer A; Badachi Y; Drouineaud V; Gouy S; Chalas C; Egels S; Dhédin N; Touraine P; Dommergues M; Lebègue G; Wolf JP; Capron F; Lefebvre G; Boissel N;
    Hum Reprod; 2019 Jun; 34(6):1083-1094. PubMed ID: 31116405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial steps in reconstruction of the human ovary: survival of pre-antral stage follicles in a decellularized human ovarian scaffold.
    Pors SE; Ramløse M; Nikiforov D; Lundsgaard K; Cheng J; Andersen CY; Kristensen SG
    Hum Reprod; 2019 Aug; 34(8):1523-1535. PubMed ID: 31286144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of ovarian tissue cryopreservation for fertility preservation: lessons learned from 545 cases.
    Jadoul P; Guilmain A; Squifflet J; Luyckx M; Votino R; Wyns C; Dolmans MM
    Hum Reprod; 2017 May; 32(5):1046-1054. PubMed ID: 28333228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological, ultrastructural and functional imaging of frozen/thawed and vitrified/warmed human ovarian tissue retrieved from oncological patients.
    Fabbri R; Vicenti R; Macciocca M; Martino NA; Dell'Aquila ME; Pasquinelli G; Morselli-Labate AM; Seracchioli R; Paradisi R
    Hum Reprod; 2016 Aug; 31(8):1838-49. PubMed ID: 27282911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center.
    Poirot C; Brugieres L; Yakouben K; Prades-Borio M; Marzouk F; de Lambert G; Pacquement H; Bernaudin F; Neven B; Paye-Jaouen A; Pondarre C; Dhedin N; Drouineaud V; Chalas C; Martelli H; Michon J; Minard V; Lezeau H; Doz F; Sarnacki S; Philippe-Chomette P; Dufour C; Laurence V; Baruchel A; Wolf JP; Boissel N; Valteau-Couanet D; Dalle JH
    Acta Obstet Gynecol Scand; 2019 May; 98(5):630-637. PubMed ID: 30919447
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.